You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BRCA1 mutation

Showing 26 - 50 of 6,944
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

BRCA Founder OutReach (BFOR) Study

Active, not recruiting
  • BRCA1 Mutation
  • BRCA2 Mutation
  • BFOR Digital Health solution/Web Portal
  • Los Angeles, California
  • +4 more
May 11, 2022

Prostatic Tumor, Prostate Cancer, BRCA2 Mutation Trial in Boston (Prostate cancer screening)

Recruiting
  • Prostatic Neoplasm
  • +7 more
  • Prostate cancer screening
  • Boston, Massachusetts
    Massachusetts General Hospital
Nov 30, 2021

Quality of Life Post Salpingo-oophorectomy in BRCA1/2 & PALB2

Recruiting
  • Hereditary Breast and Ovarian Cancer
    • Barcelona, Spain
      Hospital de la Santa Creu i Sant Pau
    Jun 3, 2022

    BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Cancer Trial in Netherlands (Salpingectomy with delayed oophorectomy,

    Active, not recruiting
    • BRCA1 Gene Mutation
    • +2 more
    • Salpingectomy with delayed oophorectomy
    • Risk-reducing salpingo-oophorectomy
    • Maastricht, Limburg, Netherlands
    • +12 more
    May 17, 2022

    Breast Cancer, Ovarian Cancer, Breast Tumors Trial in Dnipro, Kyiv (Axitinib)

    Enrolling by invitation
    • Breast Cancer
    • +7 more
    • Dnipro, Ukraine
    • +1 more
    Jun 17, 2023

    BRCA1 Mutation, Breast Cancer, Breast Diseases Trial in United States (Denosumab, Placebo, Quality-of-Life Assessment)

    Not yet recruiting
    • BRCA1 Mutation
    • +5 more
    • (no location specified)
    Jul 19, 2021

    InheriteD brEast caNcer iTalian regIsTrY A

    Recruiting
    • Breast Cancer
      • Aviano, Pordenone, Italy
      • +11 more
      Apr 26, 2023

      ATM Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Sacramento (Niraparib, Niraparib Tosylate Monohydrate,

      Recruiting
      • ATM Gene Mutation
      • +16 more
      • Sacramento, California
        University of California Davis Comprehensive Cancer Center
      Oct 27, 2022

      Hereditary Breast and Ovarian Cancer Trial in Cologne, Kiel, Munich (Structured exercise training plus mediterranean diet)

      Active, not recruiting
      • Hereditary Breast and Ovarian Cancer
      • Structured exercise training plus mediterranean diet
      • Cologne, Germany
      • +2 more
      Oct 25, 2022

      Metastatic Breast Cancer, Locally Advanced Breast Cancer, Advanced Breast Cancer Trial in Philadelphia (Palbociclib, Olaparib,

      Recruiting
      • Metastatic Breast Cancer
      • +4 more
      • Philadelphia, Pennsylvania
        Abramson Cancer Center of the University of Pennsylvania
      Jul 20, 2021

      Investigate Adaptation and Evolution of Ovarian High-grade

      Recruiting
      • Ovarian Cancer
      • +6 more
        • Bristol, United Kingdom
        • +10 more
        Sep 8, 2022

        Metastatic Castration-resistant Prostate Cancer Trial in Guangzhou (Pamiparib)

        Recruiting
        • Metastatic Castration-resistant Prostate Cancer
        • Guangzhou, Guangdong, China
          Sun Yat-sen University Cancer Center
        Apr 7, 2022

        ARID1A Gene Mutation, ATM Gene Mutation, ATR Gene Mutation Trial in United States (Olaparib)

        Recruiting
        • ARID1A Gene Mutation
        • +15 more
        • Scottsdale, Arizona
        • +4 more
        Dec 13, 2022

        BRCA1 Mutation, BRCA2 Mutation Trial in Philadelphia (Disclosure Toolkit)

        Recruiting
        • BRCA1 Mutation
        • BRCA2 Mutation
        • Disclosure Toolkit
        • Philadelphia, Pennsylvania
          Abramson Cancer Center
        Jun 2, 2021

        Depression and Body Image Distress Following Mastectomy With

        Completed
        • Breast Cancer
        • +2 more
        • Psychosocial variables
        • Boston, Massachusetts
          Massachusetts General Hospital
        Aug 5, 2021

        Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8 Trial (Biospecimen Collection,

        Not yet recruiting
        • Prostate Adenocarcinoma
        • +2 more
        • Biospecimen Collection
        • +6 more
        • (no location specified)
        Mar 28, 2023

        Breast Cancer Female, BRCA1 Mutation, BRCA2 Mutation Trial in Paris, Clermont-Ferrand, Beaumont (liquid biopsy)

        Recruiting
        • Breast Cancer Female
        • +2 more
        • liquid biopsy
        • Paris, Ile De France, France
        • +5 more
        Mar 24, 2022

        Stage I Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer Trial in United States (Niraparib, Dostarlimab)

        Recruiting
        • Stage I Breast Cancer
        • +7 more
        • Baltimore, Maryland
        • +6 more
        Nov 11, 2022

        BRCA1/2 Mutation Trial in Philadelphia (INO-5401, INO-9012, Cellectra 2000)

        Recruiting
        • BRCA1/2 Mutation
        • Philadelphia, Pennsylvania
          University of Pennsylvania
        Dec 7, 2021

        Molecular Profiling in Prostate Cancer

        Recruiting
        • Prostate Cancer Metastatic
        • +4 more
        • Tumor molecular profiling
        • Athens, Greece
          Hellenic Cooperative Oncology Group
        Mar 15, 2022

        Advanced Malignant Tumor, ATM Gene Mutation, BRCA1 Gene Mutation Trial in Houston (Laboratory Biomarker Analysis,

        Active, not recruiting
        • Advanced Malignant Neoplasm
        • +7 more
        • Laboratory Biomarker Analysis
        • +2 more
        • Houston, Texas
          M D Anderson Cancer Center
        Feb 21, 2022

        Impact of Positive BRCA1/2 Mutation Status on Lives of Young

        Completed
        • BRCA1 Gene
        • BRCA2 Gene
          • Bethesda, Maryland
            National Cancer Institute (NCI), 9000 Rockville Pike
          Nov 26, 2021

          Advanced Breast Cancer, HER2/Neu Negative, Triple-Negative Breast Cancer Trial in Stanford (Talazoparib Tosylate)

          Active, not recruiting
          • Advanced Breast Cancer
          • +2 more
          • Talazoparib Tosylate
          • Stanford, California
            Stanford University Hospitals and Clinics
          Nov 16, 2022

          BARD1 Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Houston, Seattle (Educational Intervention, Genetic

          Recruiting
          • BARD1 Gene Mutation
          • +14 more
          • Educational Intervention
          • +3 more
          • Houston, Texas
          • +1 more
          Jun 14, 2022

          BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Columbus (Informational Intervention, Survey Administration)

          Recruiting
          • BRCA1 Gene Mutation
          • BRCA2 Gene Mutation
          • Informational Intervention
          • Survey Administration
          • Columbus, Ohio
            Ohio State University Comprehensive Cancer Center
          Mar 2, 2022